056927343	056927343	CD	B-NP	O
|	|	NN	I-NP	O
IH	IH	NN	I-NP	O
|	|	NN	I-NP	O
76771806	76771806	CD	I-NP	O
|	|	NN	I-NP	O
|	|	NN	I-NP	O
3231810	3231810	CD	B-NP	O
|	|	CC	I-NP	O
1/15/2006	1/15/2006	CD	I-NP	O
12	12	CD	I-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
AM	AM	VBP	B-VP	O
|	|	JJ	B-NP	B-protein
Chest	Chest	NNP	I-NP	I-protein
discomfort	discomfort	NN	I-NP	I-protein
|	|	NN	I-NP	I-protein
|	|	NNP	I-NP	I-protein
DIS	DIS	NNP	I-NP	I-protein
|	|	NNP	I-NP	I-protein
Admission	Admission	NNP	I-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
4/25/2006	4/25/2006	CD	B-NP	O
Report	Report	NNP	I-NP	O
Status	Status	NNP	I-NP	O
:	:	:	O	O
Discharge	Discharge	NNP	B-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
8/13/2006	8/13/2006	CD	B-NP	O
******	******	SYM	I-NP	O
FINAL	FINAL	NN	I-NP	O
DISCHARGE	DISCHARGE	NN	I-NP	O
ORDERS	ORDERS	NNS	I-NP	O
******	******	SYM	O	O
CAYLOR	CAYLOR	NNP	B-NP	O
,	,	,	O	O
LLOYD	LLOYD	NNP	B-NP	O
J	J	NNP	I-NP	O
589-83-85-2	589-83-85-2	CD	I-NP	O
Gleburb	Gleburb	NNP	I-NP	O
Service	Service	NNP	I-NP	O
:	:	:	O	O
RNM	RNM	NN	B-NP	O
DISCHARGE	DISCHARGE	NN	I-NP	O
PATIENT	PATIENT	NN	I-NP	O
ON	ON	NN	I-NP	O
:	:	:	O	O
9/4/06	9/4/06	CD	B-NP	O
AT	AT	NN	I-NP	O
11	11	CD	I-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
AM	AM	NNP	I-NP	O
CONTINGENT	CONTINGENT	NNP	I-NP	O
UPON	UPON	NNP	I-NP	O
Not	Not	NNP	I-NP	O
Applicable	Applicable	NNP	I-NP	O
WILL	WILL	NNP	I-NP	O
D/C	D/C	NNP	I-NP	O
ORDER	ORDER	NNP	I-NP	O
BE	BE	NNP	I-NP	O
USED	USED	NNP	I-NP	O
AS	AS	NNP	I-NP	O
THE	THE	NNP	I-NP	O
D/C	D/C	NNP	I-NP	O
SUMMARY	SUMMARY	NNP	I-NP	O
:	:	:	O	O
YES	YES	NNP	B-NP	O
Attending	Attending	NNP	I-NP	O
:	:	:	O	O
SLIKER	SLIKER	NN	B-NP	O
,	,	,	O	O
HENRY	HENRY	NNP	B-NP	O
A.	A.	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
CODE	CODE	NNP	I-NP	O
STATUS	STATUS	NNP	I-NP	O
:	:	:	O	O
Full	Full	JJ	B-NP	O
code	code	NN	I-NP	O
DISPOSITION	DISPOSITION	NN	I-NP	O
:	:	:	O	O
Home	Home	NN	B-NP	O
DISCHARGE	DISCHARGE	NN	I-NP	O
MEDICATIONS	MEDICATIONS	NNS	I-NP	O
:	:	:	O	O
TYLENOL	TYLENOL	NN	B-NP	O
-LRB-	-LRB-	NN	I-NP	O
ACETAMINOPHEN	ACETAMINOPHEN	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
650	650	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
Q4H	Q4H	NNP	I-NP	O
PRN	PRN	NNP	I-NP	O
Headache	Headache	NNP	I-NP	O
ACETYLSALICYLIC	ACETYLSALICYLIC	NNP	I-NP	O
ACID	ACID	NNP	I-NP	O
81	81	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
DAILY	DAILY	NNP	I-NP	O
Override	Override	NNP	I-NP	O
Notice	Notice	NNP	I-NP	O
:	:	:	O	O
Override	Override	NNP	B-NP	O
added	add	VBD	B-VP	O
on	on	IN	B-PP	O
6/5/06	6/5/06	CD	B-NP	O
by	by	IN	B-PP	O
ROSENBLOOM	ROSENBLOOM	NN	B-NP	O
,	,	,	O	O
GARTH	GARTH	NN	B-NP	B-protein
,	,	,	O	O
M.D.	M.D.	NN	B-NP	O
on	on	IN	B-PP	O
order	order	NN	B-NP	O
for	for	IN	B-PP	O
COUMADIN	COUMADIN	NN	B-NP	O
PO	PO	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
ref	ref	NN	I-NP	O
#	#	#	B-NP	O
344408900	344408900	CD	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
ASPIRIN	ASPIRIN	NNP	B-NP	O
&	&	CC	I-NP	O
WARFARIN	WARFARIN	NNP	I-NP	O
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
aware	aware	JJ	B-NP	O
ALLOPURINOL	ALLOPURINOL	NN	I-NP	O
100	100	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
DAILY	DAILY	NNP	I-NP	O
Override	Override	NNP	I-NP	O
Notice	Notice	NNP	I-NP	O
:	:	:	O	O
Override	Override	NNP	B-NP	O
added	add	VBD	B-VP	O
on	on	IN	B-PP	O
6/5/06	6/5/06	CD	B-NP	O
by	by	IN	B-PP	O
HANNEMANN	HANNEMANN	NN	B-NP	O
,	,	,	O	O
RUSTY	RUSTY	NN	B-NP	O
,	,	,	O	O
M.D.	M.D.	NN	B-NP	O
on	on	IN	B-PP	O
order	order	NN	B-NP	O
for	for	IN	B-PP	O
COUMADIN	COUMADIN	NN	B-NP	O
PO	PO	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
ref	ref	NN	I-NP	O
#	#	#	B-NP	O
344408900	344408900	CD	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
ALLOPURINOL	ALLOPURINOL	NNP	B-NP	O
&	&	CC	I-NP	O
WARFARIN	WARFARIN	NNP	I-NP	O
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
aware	aware	JJ	B-NP	O
NORVASC	NORVASC	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
AMLODIPINE	AMLODIPINE	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
10	10	CD	I-NP	O
MG	MG	NN	I-NP	O
PO	PO	NN	I-NP	O
DAILY	DAILY	NN	I-NP	O
HOLD	HOLD	NN	I-NP	O
IF	IF	NN	I-NP	O
:	:	:	O	O
SBP	SBP	NN	B-NP	B-protein
<	<	SYM	O	O
120	120	CD	B-NP	O
Food/Drug	Food/Drug	NNP	I-NP	O
Interaction	Interaction	NNP	I-NP	O
Instruction	Instruction	NNP	I-NP	O
Avoid	Avoid	NNP	I-NP	O
grapefruit	grapefruit	NN	I-NP	O
unless	unless	IN	B-SBAR	O
MD	MD	NN	B-NP	B-DNA
instructs	instruct	NNS	I-NP	I-DNA
otherwise	otherwise	RB	B-ADVP	O
.	.	.	O	O

PHOSLO	PHOSLO	NN	B-NP	O
-LRB-	-LRB-	NNP	I-NP	O
CALCIUM	CALCIUM	NNP	I-NP	O
ACETATE	ACETATE	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
1	1	CD	I-NP	O
GELCAP	GELCAP	NN	I-NP	O
=	=	SYM	B-VP	O
667	667	CD	B-NP	O
MG	MG	NN	I-NP	O
-RRB-	-RRB-	SYM	B-NP	O
-RRB-	-RRB-	NN	B-NP	O
1	1	CD	I-NP	O
,	,	,	I-NP	O
334	334	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
TID	TID	NNP	I-NP	O
Instructions	Instruction	NNPS	I-NP	O
:	:	:	O	O
to	to	TO	B-VP	O
be	be	VB	I-VP	O
taken	take	VBN	I-VP	O
with	with	IN	B-PP	O
meals	meal	NNS	B-NP	O
only	only	RB	B-ADVP	O
--	--	:	O	O
no	no	DT	B-NP	O
need	need	NN	I-NP	O
to	to	TO	B-VP	O
give	give	VB	I-VP	O
if	if	IN	B-SBAR	O
NPO	NPO	NNP	B-NP	B-protein
COLACE	COLACE	NNP	I-NP	I-protein
-LRB-	-LRB-	NNP	I-NP	I-protein
DOCUSATE	DOCUSATE	NNP	I-NP	I-protein
SODIUM	SODIUM	NNP	I-NP	I-protein
-RRB-	-RRB-	NNP	I-NP	I-protein
100	100	CD	I-NP	I-protein
MG	MG	NNP	I-NP	I-protein
PO	PO	NNP	I-NP	I-protein
BID	BID	NNP	I-NP	I-protein
GLIPIZIDE	GLIPIZIDE	NNP	I-NP	I-protein
10	10	CD	I-NP	I-protein
MG	MG	NNP	I-NP	I-protein
PO	PO	NNP	I-NP	I-protein
DAILY	DAILY	NNP	I-NP	I-protein
Starting	Starting	NNP	I-NP	I-protein
Today	Today	NNP	I-NP	I-protein
August	August	NNP	I-NP	I-protein
LISINOPRIL	LISINOPRIL	NNP	I-NP	I-protein
2.5	2.5	CD	I-NP	I-protein
MG	MG	NNP	I-NP	I-protein
PO	PO	NNP	I-NP	I-protein
DAILY	DAILY	NNP	I-NP	I-protein
MAALOX-TABLETS	MAALOX-TABLETS	NNP	I-NP	I-protein
QUICK	QUICK	NNP	I-NP	I-protein
DISSOLVE/CHEWABLE	DISSOLVE/CHEWABLE	NNP	I-NP	I-protein
1-2	1-2	NN	I-NP	I-protein
TAB	TAB	NNP	I-NP	I-protein
PO	PO	NNP	I-NP	O
Q6H	Q6H	NNP	I-NP	O
PRN	PRN	NNP	I-NP	O
Upset	Upset	NNP	I-NP	O
Stomach	Stomach	NNP	I-NP	O
TOPROL	TOPROL	NNP	I-NP	O
XL	XL	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
METOPROLOL	METOPROLOL	NNP	I-NP	O
SUCCINATE	SUCCINATE	NNP	I-NP	O
EXTENDED	EXTENDED	NNP	I-NP	O
RELEASE	RELEASE	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
150	150	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
DAILY	DAILY	NNP	I-NP	O
Food/Drug	Food/Drug	NNP	I-NP	O
Interaction	Interaction	NNP	I-NP	O
Instruction	Instruction	NNP	I-NP	O
Take	Take	NNP	I-NP	O
consistently	consistently	RB	B-ADVP	O
with	with	IN	B-PP	O
meals	meal	NNS	B-NP	O
or	or	CC	B-PP	O
on	on	IN	B-PP	O
empty	empty	JJ	B-NP	O
stomach	stomach	NN	I-NP	O
.	.	.	O	O

NEPHROCAPS	NEPHROCAPS	NN	B-NP	O
-LRB-	-LRB-	NN	I-NP	O
NEPHRO-VIT	NEPHRO-VIT	NN	I-NP	O
RX	RX	NN	I-NP	O
-RRB-	-RRB-	HYPH	B-NP	O
1	1	CD	I-NP	O
TAB	TAB	NN	I-NP	B-protein
PO	PO	NNP	I-NP	O
DAILY	DAILY	NNP	I-NP	O
Override	Override	NNP	I-NP	O
Notice	Notice	NNP	I-NP	O
:	:	:	O	O
Override	Override	NNP	B-NP	O
added	add	VBD	B-VP	O
on	on	IN	B-PP	O
6/5/06	6/5/06	CD	B-NP	O
by	by	IN	B-PP	O
PAGNOZZI	PAGNOZZI	NN	B-NP	O
,	,	,	O	O
MARTY	MARTY	NN	B-NP	O
,	,	,	O	O
M.D.	M.D.	NN	B-NP	O
on	on	IN	B-PP	O
order	order	NN	B-NP	O
for	for	IN	B-PP	O
ZOCOR	ZOCOR	NN	B-NP	B-protein
PO	PO	NN	I-NP	I-protein
-LRB-	-LRB-	NN	I-NP	I-protein
ref	ref	NN	I-NP	I-protein
#	#	#	B-NP	I-protein
172961316	172961316	CD	I-NP	I-protein
-RRB-	-RRB-	NNP	I-NP	I-protein
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
NIACIN	NIACIN	NN	B-NP	B-protein
,	,	,	O	O
VIT	VIT	NN	B-NP	B-protein
.	.	.	O	O

B-3	B-3	NN	B-NP	B-protein
&	&	CC	I-NP	O
SIMVASTATIN	SIMVASTATIN	NN	I-NP	O
Reason	Reason	NN	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
aware	aware	JJ	B-NP	O
ZOCOR	ZOCOR	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
SIMVASTATIN	SIMVASTATIN	NN	I-NP	O
-RRB-	-RRB-	,	O	O
40	40	CD	B-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
BEDTIME	BEDTIME	NNP	I-NP	O
Food/Drug	Food/Drug	NNP	I-NP	O
Interaction	Interaction	NNP	I-NP	O
Instruction	Instruction	NNP	I-NP	O
Avoid	Avoid	NNP	I-NP	O
grapefruit	grapefruit	NN	I-NP	O
unless	unless	IN	B-SBAR	O
MD	MD	NN	B-NP	B-DNA
instructs	instruct	NNS	I-NP	I-DNA
otherwise	otherwise	RB	B-ADVP	O
.	.	.	O	O

Override	Override	NNP	B-NP	O
Notice	Notice	NNP	I-NP	O
:	:	:	O	O
Override	Override	NNP	B-NP	O
added	add	VBD	B-VP	O
on	on	IN	B-PP	O
6/5/06	6/5/06	CD	B-NP	O
by	by	IN	B-PP	O
KOPFER	KOPFER	NN	B-NP	O
,	,	,	O	O
TOBIAS	TOBIAS	NN	B-NP	O
,	,	,	O	O
M.D.	M.D.	NN	B-NP	O
on	on	IN	B-PP	O
order	order	NN	B-NP	O
for	for	IN	B-PP	O
COUMADIN	COUMADIN	NN	B-NP	O
PO	PO	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
ref	ref	NN	I-NP	O
#	#	#	B-NP	O
344408900	344408900	CD	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
SIMVASTATIN	SIMVASTATIN	NNP	B-NP	O
&	&	CC	I-NP	O
WARFARIN	WARFARIN	NNP	I-NP	O
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
aware	aware	JJ	B-NP	O
Previous	Previous	JJ	I-NP	O
override	override	NN	I-NP	O
information	information	NN	I-NP	O
:	:	:	O	O
Override	Override	NN	B-NP	O
added	add	VBN	B-VP	O
on	on	IN	B-PP	O
6/5/06	6/5/06	CD	B-NP	O
by	by	IN	B-PP	O
MCLAINE	MCLAINE	NNP	B-NP	O
,	,	,	O	O
RENALDO	RENALDO	NNP	B-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
NIACIN	NIACIN	NN	B-NP	B-protein
,	,	,	O	O
VIT	VIT	NN	B-NP	B-protein
.	.	.	O	O

B-3	B-3	NN	B-NP	B-protein
&	&	CC	I-NP	O
SIMVASTATIN	SIMVASTATIN	NN	I-NP	O
Reason	Reason	NN	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
aware	aware	JJ	B-NP	O
COUMADIN	COUMADIN	NN	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
WARFARIN	WARFARIN	NNP	I-NP	O
SODIUM	SODIUM	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
10	10	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
QPM	QPM	NNP	I-NP	O
Starting	Starting	NNP	I-NP	O
NOW	NOW	NNP	I-NP	O
,	,	,	O	O
Within	Within	NNP	B-NP	O
Hour	Hour	NNP	I-NP	O
of	of	IN	B-PP	O
Pharmacy	Pharmacy	NNP	B-NP	O
Approval	Approval	NNP	I-NP	O
Instructions	Instruction	NNPS	I-NP	O
:	:	:	O	O
Please	Please	NN	B-NP	B-protein
start	start	VB	B-VP	O
this	this	DT	B-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
am	am	NN	I-NP	O
of	of	IN	B-PP	O
4/28/06	4/28/06	CD	B-NP	O
Food/Drug	Food/Drug	NN	I-NP	O
Interaction	Interaction	NN	I-NP	O
Instruction	Instruction	NN	I-NP	O
No	No	DT	B-NP	O
high	high	JJ	I-NP	O
Vitamin-K	Vitamin-K	NN	I-NP	O
containing	contain	VBG	B-VP	O
foods	food	NNS	B-NP	O
Alert	Alert	NNP	B-NP	O
overridden	overridden	JJ	B-ADJP	O
:	:	:	O	O
Override	Override	NN	B-NP	O
added	add	VBN	B-VP	O
on	on	IN	B-PP	O
6/5/06	6/5/06	CD	B-NP	O
by	by	IN	B-PP	O
PAILLET	PAILLET	NNP	B-NP	O
,	,	,	O	O
WILMER	WILMER	NNP	B-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
ASPIRIN	ASPIRIN	NNP	B-NP	O
&	&	CC	I-NP	O
WARFARIN	WARFARIN	NNP	I-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
SIMVASTATIN	SIMVASTATIN	NNP	B-NP	O
&	&	CC	I-NP	O
WARFARIN	WARFARIN	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
ALLOPURINOL	ALLOPURINOL	NNP	B-NP	O
&	&	CC	I-NP	O
WARFARIN	WARFARIN	NNP	I-NP	O
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
aware	aware	JJ	B-NP	O
DIET	DIET	NN	I-NP	O
:	:	:	O	O
House	House	NNP	B-NP	O
/	/	SYM	B-NP	O
Renal	Renal	JJ	I-NP	O
diet	diet	NN	I-NP	O
/	/	SYM	B-NP	O
Fluid	Fluid	NN	I-NP	O
Restriction	Restriction	NN	I-NP	O
less	less	JJR	B-NP	O
than	than	IN	I-NP	O
1.5	1.5	CD	I-NP	O
L	L	NN	I-NP	O
per	per	IN	B-PP	O
day	day	NN	B-NP	O
ACTIVITY	ACTIVITY	NN	I-NP	O
:	:	:	O	O
Walking	Walk	VBG	B-VP	O
as	as	IN	B-SBAR	O
tolerated	tolerate	VBN	B-NP	O
FOLLOW	FOLLOW	NNP	I-NP	O
UP	UP	NNP	I-NP	O
APPOINTMENT	APPOINTMENT	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
S	S	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
:	:	:	O	O
Dr.	Dr.	NNP	B-NP	O
Bagshaw	Bagshaw	NNP	I-NP	O
in	in	IN	B-PP	O
Walk	Walk	NNP	B-NP	O
,	,	,	O	O
Please	Please	NNP	B-NP	O
schedule	schedule	NN	I-NP	O
for	for	IN	B-PP	O
a	a	DT	B-NP	O
cardiac	cardiac	JJ	I-NP	O
stress	stress	NN	I-NP	O
test	test	NN	I-NP	O
,	,	,	O	O
Arrange	Arrange	NNP	B-NP	O
INR	INR	NNP	I-NP	O
to	to	TO	B-VP	O
be	be	VB	I-VP	O
drawn	draw	VBN	I-VP	O
on	on	IN	B-PP	O
4/28/06	4/28/06	CD	B-NP	O
with	with	IN	B-PP	O
f/u	f/u	NN	B-NP	O
INR	INR	NNP	B-NP	O
's	's	POS	B-NP	O
to	to	TO	B-VP	O
be	be	VB	I-VP	O
drawn	draw	VBN	I-VP	O
every	every	DT	B-NP	O
2	2	CD	I-NP	O
days	day	NNS	I-NP	O
.	.	.	O	O

INR	INR	NN	B-NP	O
's	's	POS	B-NP	O
will	will	MD	B-VP	O
be	be	VB	I-VP	O
followed	follow	VBN	I-VP	O
by	by	IN	B-PP	O
Dr.	Dr.	NNP	B-NP	O
Tynio	Tynio	NNP	I-NP	O
ALLERGY	ALLERGY	NNP	I-NP	O
:	:	:	O	O
NKA	NKA	NN	B-NP	O
ADMIT	ADMIT	NN	I-NP	O
DIAGNOSIS	DIAGNOSIS	NN	I-NP	O
:	:	:	O	O
Chest	Ch	JJS	B-NP	O
discomfort	discomfort	NN	I-NP	O
PRINCIPAL	PRINCIPAL	NN	I-NP	O
DISCHARGE	DISCHARGE	NN	I-NP	O
DIAGNOSIS	DIAGNOSIS	NN	I-NP	O
;	;	:	O	O
Responsible	Responsible	JJ	B-ADJP	O
After	After	IN	B-PP	O
Study	Study	NNP	B-NP	O
for	for	IN	B-PP	O
Causing	Causing	NNP	B-NP	O
Admission	Admission	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
Chest	Chest	NNP	I-NP	O
discomfort	discomfort	NN	I-NP	O
OTHER	OTHER	NNP	I-NP	O
DIAGNOSIS	DIAGNOSIS	NNP	I-NP	O
;	;	:	O	O
Conditions	Condition	NNS	B-NP	O
,	,	,	O	O
Infections	Infection	NNS	B-NP	O
,	,	,	O	O
Complications	Complication	NNS	B-NP	O
,	,	,	O	O
affecting	affect	VBG	B-VP	O
Treatment/Stay	Treatment/Stay	NNP	B-NP	O
diabetes	diabetes	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
diabetes	diabetes	NN	I-NP	O
mellitus	mellitus	NN	I-NP	O
type	type	NN	I-NP	O
2	2	CD	I-NP	O
-RRB-	-RRB-	HYPH	I-NP	O
polycystic	polycystic	JJ	I-NP	O
kidney	kidney	NN	I-NP	O
disease	disease	NN	I-NP	O
-LRB-	-LRB-	HYPH	B-NP	O
polycystic	polycystic	JJ	I-NP	O
kidneys	kidney	NNS	I-NP	O
-RRB-	-RRB-	TO	B-PP	O
hypertension	hypertension	NN	B-NP	O
-LRB-	-LRB-	NN	I-NP	O
hypertension	hypertension	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
cri	cri	NN	I-NP	O
-LRB-	-LRB-	HYPH	B-NP	O
chronic	chronic	JJ	I-NP	O
renal	renal	JJ	I-NP	O
dysfunction	dysfunction	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
OPERATIONS	OPERATIONS	NNS	I-NP	O
AND	AND	CC	I-NP	O
PROCEDURES	PROCEDURES	NNS	I-NP	O
:	:	:	O	O
NONE	NONE	NN	B-NP	O
OTHER	OTHER	NN	I-NP	O
TREATMENTS/PROCEDURES	TREATMENTS/PROCEDURES	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
NOT	NOT	NNP	I-NP	O
IN	IN	NNP	I-NP	O
O.R.	O.R.	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
ROMI	ROMI	NNP	I-NP	O
BRIEF	BRIEF	NNP	I-NP	O
RESUME	RESUME	NNP	I-NP	O
OF	OF	IN	B-PP	O
HOSPITAL	HOSPITAL	NNP	B-NP	O
COURSE	COURSE	NNP	I-NP	O
:	:	:	O	O
PI	PI	NN	B-NP	O
:	:	:	O	O
36M	36M	NN	B-NP	O
w/ESRD	w/ESRD	NN	I-NP	O
on	on	IN	B-PP	O
HD	HD	NN	B-NP	O
,	,	,	O	O
well-controlled	well-controlled	JJ	B-NP	O
type	type	NN	I-NP	O
II	II	CD	I-NP	O
DM	DM	NN	I-NP	O
x	x	SYM	B-NP	O
10	10	CD	B-NP	O
years	year	NNS	I-NP	O
,	,	,	O	O
HTN	HTN	NN	B-NP	B-protein
,	,	,	O	O
and	and	CC	O	O
recently	recently	RB	B-ADVP	O
dx	dx	NN	B-NP	O
R.	R.	NNP	I-NP	O
IJ	IJ	NNP	I-NP	O
catheter-associated	catheter-associate	VBD	B-VP	O
DVT	DVT	NNP	B-NP	O
presented	present	VBD	B-VP	O
to	to	TO	B-VP	O
ED	ED	VBN	I-VP	O
after	after	IN	B-PP	O
episodes	episode	NNS	B-NP	O
of	of	IN	B-PP	O
chest	chest	NN	B-NP	O
`	`	``	B-VP	O
pounding	pound	VBG	I-VP	O
'	'	''	O	O
during	during	IN	B-PP	O
and	and	CC	I-PP	O
after	after	IN	I-PP	O
HD	HD	NN	B-NP	O
today	today	NN	B-NP	O
.	.	.	O	O

Towards	Towards	IN	B-PP	O
end	end	NN	B-NP	O
of	of	IN	B-PP	O
HD	HD	NN	B-NP	B-protein
run	run	NN	I-NP	I-protein
,	,	,	O	O
developed	develop	VBD	B-VP	O
a	a	DT	B-NP	O
`	`	``	I-NP	O
pounding	pound	VBG	I-NP	O
'	'	''	I-NP	O
sensation	sensation	NN	I-NP	O
in	in	IN	B-PP	O
his	his	PRP$	B-NP	O
L.	L.	NNP	I-NP	O
upper	upper	JJ	I-NP	O
chest/axilla	chest/axilla	NN	I-NP	O
,	,	,	O	O
which	which	WDT	B-NP	O
lasted	last	VBD	B-VP	O
for	for	IN	B-PP	O
~	~	NN	B-NP	O
20	20	CD	B-NP	O
seconds	second	NNS	I-NP	O
,	,	,	O	O
then	then	RB	B-ADVP	O
resolved	resolve	VBD	B-VP	O
spontaneously	spontaneously	RB	B-ADVP	O
.	.	.	O	O

No	No	DT	B-NP	O
associated	associate	VBN	I-NP	O
dyspnea	dyspnea	NN	I-NP	O
,	,	,	O	O
diaphoresis	diaphoresis	NN	B-NP	O
,	,	,	O	O
nausea	nausea	NN	B-NP	O
,	,	,	O	O
vomiting	vomit	VBG	B-VP	O
,	,	,	O	O
palpitations	palpitation	NNS	B-NP	O
.	.	.	O	O

Developed	Develop	VBN	B-VP	O
another	another	DT	B-NP	O
episode	episode	NN	I-NP	O
of	of	IN	B-PP	O
`	`	``	O	O
pressure	pressure	NN	B-NP	O
'	'	''	O	O
in	in	IN	B-PP	O
his	his	PRP$	B-NP	O
L.	L.	NNP	I-NP	O
lateral	lateral	JJ	I-NP	O
chest	chest	NN	I-NP	O
after	after	IN	B-PP	O
HD	HD	NN	B-NP	O
complete	complete	JJ	B-ADJP	O
,	,	,	O	O
lasted	last	VBN	B-VP	O
for	for	IN	B-PP	O
4-5	4-5	CD	B-NP	O
hours	hour	NNS	I-NP	O
,	,	,	O	O
constant	constant	NN	B-NP	O
,	,	,	O	O
no	no	DT	B-NP	O
exacerbating	exacerbate	VBG	I-NP	O
or	or	CC	I-VP	O
alleviating	alleviate	VBG	I-VP	B-protein
factors	factor	NNS	B-NP	I-protein
,	,	,	O	O
nonpositional	nonpositional	JJ	B-NP	O
,	,	,	I-NP	O
exertional	exertional	JJ	I-NP	O
,	,	,	O	O
or	or	CC	O	O
pleuritic	pleuritic	JJ	B-ADVP	O
;	;	:	O	O
again	again	RB	B-ADVP	O
,	,	,	O	O
no	no	DT	B-NP	O
associated	associated	JJ	I-NP	O
symptoms	symptom	NNS	I-NP	O
.	.	.	O	O

Exercise	Exercise	NN	B-NP	O
tolerance	tolerance	NN	I-NP	O
has	have	VBZ	B-VP	O
been	be	VBN	I-VP	O
stable	stable	JJ	B-ADJP	O
recently	recently	RB	B-ADVP	O
;	;	:	O	O
works	work	NNS	B-NP	O
,	,	,	O	O
climbs	climb	VBZ	B-VP	O
few	few	JJ	B-NP	O
flights	flight	NNS	I-NP	O
of	of	IN	B-PP	O
stairs	stair	NNS	B-NP	O
without	without	IN	B-PP	O
significant	significant	JJ	B-NP	O
dyspnea	dyspnea	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
without	without	IN	B-PP	O
any	any	DT	B-NP	O
chest	ch	JJS	I-NP	O
pain	pain	NN	I-NP	O
.	.	.	O	O

Dx	Dx	NN	B-NP	B-protein
w	w	NN	I-NP	I-protein
/	/	SYM	B-NP	O
R.	R.	NN	I-NP	B-protein
IJ	IJ	NN	I-NP	I-protein
catheter-associated	catheter-associated	JJ	I-NP	O
DVT	DVT	NN	I-NP	O
5/6	5/6	CD	I-NP	O
after	after	IN	B-PP	O
presenting	present	VBG	B-VP	O
to	to	TO	B-PP	O
ED	ED	NNP	B-NP	O
with	with	IN	B-PP	O
R.	R.	NNP	B-NP	O
neck	neck	NN	I-NP	O
pain	pain	NN	I-NP	O
;	;	:	O	O
sent	send	VBN	B-NP	O
home	home	NN	I-NP	O
on	on	IN	B-PP	O
renally	renally	RB	B-NP	O
dosed	dose	VBN	I-NP	O
lovenox	lovenox	NN	I-NP	O
and	and	CC	I-NP	O
coumadin	coumadin	NN	I-NP	O
--	--	:	O	O
pain	pain	NN	B-NP	O
has	have	VBZ	B-VP	O
improved	improve	VBN	I-VP	O
on	on	IN	B-PP	O
lovenox/coumadin	lovenox/coumadin	NN	B-NP	O
.	.	.	O	O

Has	Ha	NNS	B-NP	B-protein
lost	lose	VBD	B-VP	O
weight	weight	NN	B-NP	O
after	after	IN	B-PP	O
starting	start	VBG	B-VP	O
HD	HD	NN	B-NP	O
.	.	.	O	O

No	No	DT	B-NP	O
F/C	F/C	NN	I-NP	O
,	,	,	O	O
no	no	DT	B-NP	O
rashes	rash	NNS	I-NP	B-protein
-LRB-	-LRB-	NN	I-NP	I-protein
although	although	IN	B-SBAR	O
diffuse	diffuse	JJ	B-NP	O
pruritus	pruritus	NN	I-NP	O
after	after	IN	B-PP	O
initiation	initiation	NN	B-NP	O
of	of	IN	B-PP	O
coumadin	coumadin	NN	B-NP	O
and	and	CC	I-NP	O
lovenox	lovenox	NN	I-NP	B-protein
-RRB-	-RRB-	NN	I-NP	I-protein
,	,	,	O	O
no	no	DT	B-NP	O
night	night	NN	I-NP	O
sweats	sweat	NNS	I-NP	O
,	,	,	O	O
fatigue	fatigue	NN	B-NP	O
,	,	,	O	O
palpitations	palpitation	NNS	B-NP	O
,	,	,	O	O
dyspnea	dyspnea	NN	B-NP	O
,	,	,	O	O
orthopnea	orthopnea	NN	B-NP	O
,	,	,	O	O
PND	PND	NN	B-NP	B-protein
,	,	,	O	O
LE	LE	NN	B-NP	O
edema	edema	NN	I-NP	O
,	,	,	O	O
abdominal	abdominal	JJ	B-NP	O
pain	pain	NN	I-NP	O
,	,	,	O	O
nausea	nausea	NN	B-NP	O
,	,	,	O	O
vomiting	vomiting	NN	B-NP	O
,	,	,	O	O
diarrhea	diarrhea	NN	B-NP	O
,	,	,	O	O
constipation	constipation	NN	B-NP	O
,	,	,	O	O
blood	blood	NN	B-NP	O
in	in	IN	B-PP	O
stools	stool	NNS	B-NP	O
,	,	,	O	O
dysuria	dysuria	NN	B-NP	O
,	,	,	O	O
hematuria	hematuria	NN	B-NP	O
.	.	.	O	O

In	In	IN	B-PP	O
ED	ED	NN	B-NP	O
,	,	,	O	O
EKG	EKG	NN	B-NP	O
notable	notable	JJ	B-ADJP	O
for	for	IN	B-PP	O
regularized	regularize	VBN	B-NP	O
T	T	NN	I-NP	O
waves	wave	NNS	I-NP	O
in	in	IN	B-PP	O
I	I	NN	B-NP	O
,	,	,	O	O
L	L	NN	B-NP	O
,	,	,	O	O
V4-V6	V4-V6	NN	B-NP	O
,	,	,	O	O
and	and	CC	O	O
II	II	CD	B-NP	O
;	;	:	O	O
no	no	DT	B-NP	O
definite	definite	JJ	I-NP	O
EKG	EKG	NN	I-NP	O
evidence	evidence	NN	I-NP	O
of	of	IN	B-PP	O
LVH	LVH	NN	B-NP	B-protein
or	or	CC	O	O
low	low	JJ	B-NP	O
voltage	voltage	NN	I-NP	O
.	.	.	O	O

Received	Receive	VBN	B-NP	O
325mg	325mg	NN	I-NP	O
ASA	ASA	NN	I-NP	O
,	,	,	O	O
had	have	VBD	B-VP	O
PE-CT	PE-CT	NN	B-NP	B-protein
,	,	,	O	O
which	which	WDT	B-NP	O
was	be	VBD	B-VP	O
notable	notable	JJ	B-ADJP	O
for	for	IN	B-PP	O
no	no	DT	B-NP	O
PE	PE	NN	I-NP	O
,	,	,	O	O
no	no	DT	B-NP	O
pleural	pleural	JJ	I-NP	O
effusions	effusion	NNS	I-NP	O
,	,	,	O	O
known	know	VBN	B-VP	O
moderate	moderate	JJ	B-NP	O
pericardial	pericardial	JJ	I-NP	O
effusion	effusion	NN	I-NP	O
;	;	:	O	O
admitted	admit	VBN	B-VP	O
for	for	IN	B-PP	O
r/o	r/o	NN	B-NP	O
MI	MI	NN	I-NP	O
.	.	.	O	O

PMH	PMH	NN	B-NP	O
:	:	:	O	O
-	-	HYPH	B-NP	O
ESRD	ESRD	NN	I-NP	O
on	on	IN	B-PP	O
HD	HD	NN	B-NP	B-protein
M/W/F	M/W/F	NN	I-NP	I-protein
at	at	IN	B-PP	O
Dencehitch	Dencehitch	NNP	B-NP	O
Hospital	Hospital	NNP	I-NP	O
--	--	:	O	O
thought	think	VBN	B-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
secondary	secondary	JJ	B-ADJP	O
to	to	TO	B-PP	O
polycystic	polycystic	JJ	B-NP	O
kidney	kidney	NN	I-NP	O
disease	disease	NN	I-NP	O
,	,	,	O	O
started	start	VBD	B-VP	O
HD	HD	NN	B-NP	O
6/10	6/10	CD	I-NP	O
due	due	JJ	B-ADJP	O
to	to	TO	B-PP	O
volume	volume	NN	B-NP	O
overload	overload	NN	I-NP	O
,	,	,	O	O
R.	R.	NNP	B-NP	O
SCL	SCL	NNP	I-NP	O
tunneled	tunnel	VBD	B-VP	O
catheter	catheter	NN	B-NP	B-protein
placed	place	VBN	B-VP	I-protein
1/8/06	1/8/06	CD	B-NP	I-protein
,	,	,	O	O
s/p	s/p	NN	B-NP	B-protein
second	second	JJ	I-NP	I-protein
L.	L.	NNP	I-NP	I-protein
arm	arm	NN	I-NP	I-protein
A-V	A-V	NN	I-NP	I-protein
fistula	fistula	NN	I-NP	I-protein
placement	placement	NN	I-NP	I-protein
2/11/06	2/11/06	CD	I-NP	I-protein
-	-	:	O	I-protein
type	type	NN	B-NP	I-protein
II	II	CD	I-NP	I-protein
DM	DM	NN	I-NP	I-protein
x	x	SYM	B-NP	I-protein
10	10	CD	B-NP	I-protein
years	year	NNS	I-NP	I-protein
,	,	,	O	O
last	last	JJ	B-NP	O
A1c	A1c	NN	I-NP	O
6.1	6.1	CD	B-NP	O
-	-	HYPH	I-NP	O
HTN	HTN	NN	I-NP	B-protein
-	-	HYPH	I-NP	O
secondary	secondary	JJ	I-NP	O
hyperparathyroidism	hyperparathyroidism	NN	I-NP	O
,	,	,	O	O
PTH	PTH	NN	B-NP	B-protein
9146/10	9146/10	CD	I-NP	I-protein
-	-	HYPH	I-NP	O
anemia	anemia	NN	I-NP	O
,	,	,	O	O
likely	likely	RB	B-ADJP	O
secondary	secondary	JJ	I-ADJP	O
to	to	TO	B-PP	O
ESRD	ESRD	NNP	B-NP	O
,	,	,	O	O
no	no	DT	B-NP	O
Fe	Fe	NN	I-NP	O
deficiency	deficiency	NN	I-NP	O
on	on	IN	B-PP	O
recent	recent	JJ	B-NP	O
Fe	Fe	NN	I-NP	O
studies	study	NNS	I-NP	O
-	-	:	O	O
gout	gout	JJ	B-NP	O
Meds	Med	NNPS	I-NP	O
:	:	:	O	O
-	-	HYPH	B-NP	O
coumadin	coumadin	NN	I-NP	O
5mg	5mg	NN	I-NP	O
qd	qd	NN	I-NP	O
-	-	HYPH	B-NP	O
lovenox	lovenox	NN	I-NP	O
60	60	CD	I-NP	O
bid	bid	NN	I-NP	O
-	-	HYPH	B-NP	O
toprol	toprol	NN	I-NP	O
300mg	300mg	CD	I-NP	O
qd	qd	NN	I-NP	O
-	-	HYPH	B-NP	O
imdur	imdur	NN	I-NP	O
30mg	30mg	CD	I-NP	O
qd	qd	NN	I-NP	O
-	-	HYPH	B-NP	O
norvasc	norvasc	NN	I-NP	O
10mg	10mg	CD	I-NP	O
qd	qd	NN	I-NP	O
-	-	HYPH	B-NP	O
lisinopril	lisinopril	NN	I-NP	O
20mg	20mg	CD	I-NP	O
qd	qd	NN	I-NP	O
-	-	HYPH	B-NP	O
hydralazine	hydralazine	NN	I-NP	O
20mg	20mg	NN	I-NP	O
PO	PO	NN	I-NP	O
bid	bid	NN	I-NP	O
-	-	HYPH	O	O
zocor	zocor	NN	B-NP	O
40mg	40mg	CD	I-NP	O
qHS	qHS	NN	I-NP	O
-	-	HYPH	B-NP	O
glucotrol	glucotrol	NN	I-NP	O
10mg	10mg	CD	I-NP	O
qd	qd	NN	I-NP	O
-	-	HYPH	B-NP	O
allopurinol	allopurinol	NN	I-NP	O
100mg	100mg	CD	I-NP	O
qd	qd	NN	I-NP	O
-	-	HYPH	O	O
phoslo	phoslo	NN	B-NP	O
1334	1334	CD	I-NP	O
mg	mg	NN	I-NP	O
tid	tid	NN	I-NP	O
-	-	HYPH	O	O
calcitriol	calcitriol	NN	B-NP	O
0.25	0.25	CD	I-NP	O
mcg	mcg	NN	I-NP	O
qd	qd	NN	I-NP	O
-	-	HYPH	B-NP	O
procrit	procrit	NN	I-NP	B-protein
10000U	10000U	NN	I-NP	I-protein
qweek	qweek	NN	I-NP	I-protein
-	-	HYPH	B-NP	O
nephrocaps	nephrocap	NNS	I-NP	O
1	1	CD	I-NP	O
tab	tab	NN	I-NP	O
qd	qd	NN	I-NP	O
Allergies	Allergy	NNS	I-NP	O
:	:	:	O	O
NKDA	NKDA	NN	B-NP	O
98.7	98.7	CD	B-NP	O
77	77	CD	I-NP	O
99-102/55	99-102/55	CD	I-NP	O
-58	-58	CD	I-NP	O
18	18	CD	I-NP	O
97	97	CD	I-NP	O
%	%	NN	I-NP	O
RA	RA	NN	I-NP	O
CV	CV	NN	I-NP	O
:	:	:	O	O
JVP	JVP	NN	B-NP	O
8cm	8cm	NN	I-NP	O
,	,	,	O	O
RRR	RRR	NN	B-NP	B-protein
,	,	,	O	O
+	+	SYM	B-NP	O
S4	S4	NN	I-NP	B-protein
,	,	,	O	O
no	no	DT	B-NP	O
rubs	rub	NNS	I-NP	O
,	,	,	O	O
no	no	DT	B-NP	O
murmurs	murmur	NNS	I-NP	O
;	;	:	O	O
pulsus	pulsus	NN	B-NP	O
:	:	:	O	O
8mmHg	8mmHg	NN	B-NP	O
,	,	,	O	O
no	no	DT	B-NP	O
tenderness	tenderness	NN	I-NP	O
to	to	TO	B-PP	O
palpation	palpation	NN	B-NP	O
of	of	IN	B-PP	O
chest	chest	NN	B-NP	B-protein
wall	wall	NN	I-NP	I-protein
ADMISSION	ADMISSION	NN	I-NP	I-protein
LABS	LABS	NN	I-NP	I-protein
:	:	:	O	O
4/25/2006	4/25/2006	CD	B-NP	O
NA	NA	NN	I-NP	O
138	138	CD	B-NP	O
,	,	,	O	O
K	K	NN	B-NP	B-cell_line
3.3	3.3	NN	I-NP	I-cell_line
,	,	,	O	O
CL	CL	NN	B-NP	B-protein
96	96	CD	I-NP	I-protein
,	,	,	O	O
CO2	CO2	NN	B-NP	O
29	29	CD	I-NP	O
,	,	,	O	O
BUN	BUN	NN	B-NP	B-DNA
36	36	CD	I-NP	I-DNA
,	,	,	O	O
CRE	CRE	NN	B-NP	B-protein
9.5	9.5	CD	I-NP	I-protein
,	,	,	O	O
EGFR	EGFR	NN	B-NP	B-protein
7	7	CD	I-NP	I-protein
,	,	,	O	O
GLU	GLU	NN	B-NP	O
84	84	CD	I-NP	O
ANION	ANION	NN	I-NP	O
13	13	CD	B-NP	O
TROP-I	TROP-I	NN	I-NP	O
<	<	SYM	O	O
ASSAY	ASSAY	NN	B-NP	O
X2	X2	NN	I-NP	O
2/24/2006	2/24/2006	CD	B-NP	O
HGBA1C	HGBA1C	NN	I-NP	O
6.1	6.1	CD	B-NP	O
HCT	HCT	NN	I-NP	O
35.6	35.6	CD	B-NP	O
MCV	MCV	NN	I-NP	O
80	80	CD	B-NP	O
PLT	PLT	NN	I-NP	O
465	465	CD	B-NP	O
RDW	RDW	NN	I-NP	O
16.3	16.3	CD	B-NP	O
%	%	NN	I-NP	O
POLY-A	POLY-A	NN	I-NP	O
66.9	66.9	CD	I-NP	O
,	,	,	I-NP	O
%	%	NN	I-NP	O
LYMPH-A	LYMPH-A	NN	I-NP	O
25.4	25.4	CD	I-NP	O
,	,	,	I-NP	O
%	%	NN	I-NP	O
MONO-A	MONO-A	NN	I-NP	O
5.2	5.2	CD	I-NP	O
,	,	,	I-NP	O
%	%	NN	I-NP	O
EOS-A	EOS-A	NN	I-NP	O
2.1	2.1	CD	I-NP	O
,	,	,	I-NP	O
%	%	NN	I-NP	O
BASO-A	BASO-A	NN	I-NP	O
0.4	0.4	CD	I-NP	O
PT	PT	NN	I-NP	O
15.6	15.6	CD	B-NP	O
,	,	,	O	O
PT-INR	PT-INR	NN	B-NP	B-protein
1.2	1.2	CD	I-NP	I-protein
,	,	,	O	O
PTT	PTT	NN	B-NP	O
83.4	83.4	CD	I-NP	O
PE-CT	PE-CT	NN	I-NP	O
:	:	:	O	O
no	no	DT	B-NP	O
PE	PE	NN	I-NP	O
,	,	,	O	O
known	know	VBN	B-VP	O
R.	R.	NNP	B-NP	O
IJ	IJ	NNP	I-NP	O
catheter-associated	catheter-associate	VBD	B-VP	O
DVT	DVT	NNP	B-NP	O
,	,	,	O	O
moderate	moderate	JJ	B-NP	O
pericardial	pericardial	JJ	I-NP	O
effusion	effusion	NN	I-NP	O
2/9	2/9	CD	I-NP	O
TTE	TTE	NN	I-NP	O
:	:	:	O	O
LVEF	LVEF	NN	B-NP	O
40	40	CD	B-NP	O
%	%	NN	I-NP	O
,	,	,	O	O
mod	mod	NN	B-NP	O
concentric	concentric	JJ	I-NP	O
LVH	LVH	NN	I-NP	O
,	,	,	O	O
global/diffuse	global/diffuse	JJ	B-NP	O
reduction	reduction	NN	I-NP	O
in	in	IN	B-PP	O
wall	wall	NN	B-NP	O
motion	motion	NN	I-NP	O
,	,	,	O	O
small-moderate	small-moderate	JJ	B-NP	O
circumferential	circumferential	JJ	I-NP	O
pericardial	pericardial	JJ	I-NP	O
effusion	effusion	NN	I-NP	O
;	;	:	O	O
2.2	2.2	CD	B-NP	O
cm	cm	NN	I-NP	O
in	in	IN	B-PP	O
maximal	maximal	JJ	B-NP	O
diameter	diameter	NN	I-NP	O
,	,	,	O	O
possible	possible	JJ	B-NP	O
increased	increase	VBN	I-NP	O
intrapericardial	intrapericardial	JJ	I-NP	O
pressures	pressure	NNS	I-NP	O
without	without	IN	B-PP	O
evidence	evidence	NN	B-NP	O
of	of	IN	B-PP	O
frank	frank	NN	B-NP	O
tamponade	tamponade	NN	I-NP	O
6/9/06	6/9/06	CD	I-NP	O
TTE	TTE	NN	I-NP	O
A/P	A/P	NN	I-NP	O
:	:	:	O	O
36M	36M	NN	B-NP	O
man	man	NN	I-NP	O
with	with	IN	B-PP	O
ESRD	ESRD	NN	B-NP	O
from	from	IN	B-PP	O
PKD	PKD	NN	B-NP	B-protein
,	,	,	O	O
known	know	VBN	B-VP	O
small	small	JJ	B-NP	B-protein
pericardial	pericardial	JJ	I-NP	I-protein
effusion	effusion	NN	I-NP	I-protein
-LRB-	-LRB-	NN	I-NP	I-protein
pulses	pulse	VBZ	B-VP	O
8mmHg	8mmHg	NNP	B-NP	O
-RRB-	-RRB-	NNP	I-NP	O
,	,	,	O	O
now	now	RB	B-VP	O
admitted	admit	VBN	I-VP	O
for	for	IN	B-PP	O
CP	CP	NN	B-NP	B-DNA
.	.	.	O	O

DDx	DDx	NN	B-NP	O
:	:	:	O	O
underdialysis	underdialysis	NN	B-NP	O
-	-	HYPH	B-ADJP	O
has	have	VBZ	B-VP	O
been	be	VBN	I-VP	O
having	have	VBG	I-VP	O
4.5	4.5	CD	B-NP	O
h	h	NN	I-NP	O
runs	run	NNS	I-NP	O
,	,	,	O	O
compliant	compliant	JJ	B-ADJP	O
with	with	IN	B-PP	O
HD	HD	NN	B-NP	O
-	-	HYPH	B-NP	O
will	will	MD	B-VP	O
check	check	VB	I-VP	O
URR	URR	NN	B-NP	B-protein
with	with	IN	B-PP	O
HD	HD	NN	B-NP	O
on	on	IN	B-PP	O
Monday	Monday	NNP	B-NP	O
?	?	.	O	O

Pleural	Pleural	JJ	B-NP	B-protein
effusion	effusion	NN	I-NP	I-protein
chk	chk	NN	I-NP	I-protein
SLE	SLE	NN	I-NP	I-protein
TB	TB	NN	I-NP	I-protein
,	,	,	O	O
-LRB-	-LRB-	JJ	B-NP	O
i.e	i.e	JJ	I-NP	O
malignancy	malignancy	NN	I-NP	O
-	-	HYPH	B-NP	O
Hx	Hx	NN	I-NP	B-protein
not	not	RB	B-NP	I-protein
suggestive	suggestive	JJ	I-NP	I-protein
-RRB-	-RRB-	NN	I-NP	I-protein
,	,	,	O	O
HIV	HIV	NN	B-NP	O
-	-	HYPH	O	O
r/o	r/o	NN	B-NP	O
with	with	IN	B-PP	O
HIV	HIV	NN	B-NP	O
test	test	NN	I-NP	O
ECHO	ECHO	NN	I-NP	O
was	be	VBD	B-VP	O
done	do	VBN	I-VP	O
today	today	NN	B-NP	O
showing	show	VBG	B-VP	O
small	small	JJ	B-NP	O
pleural	pleural	JJ	I-NP	O
effusion	effusion	NN	I-NP	O
.	.	.	O	O

3	3	LS	B-LST	O
.	.	.	O	O

Hypotension-has	Hypotension-has	JJ	B-NP	O
no	no	DT	I-NP	O
pulsus	pulsus	NN	I-NP	O
,	,	,	O	O
so	so	RB	B-ADJP	O
unlikely	unlikely	JJ	I-ADJP	O
to	to	TO	B-VP	O
be	be	VB	I-VP	O
tamponade	tamponade	VBN	I-VP	O
/	/	SYM	B-PP	O
no	no	DT	B-NP	O
pulses	pulse	NNS	I-NP	O
.	.	.	O	O

Change	Change	NN	B-NP	O
BP	BP	NN	I-NP	O
medication	medication	NN	I-NP	O
regimen	regimen	NN	I-NP	O
.	.	.	O	O

Toprol	Toprol	NNP	B-NP	O
XL	XL	NNP	I-NP	O
300mg	300mg	CD	I-NP	O
QD	QD	NNP	I-NP	O
--	--	:	O	O
>	>	SYM	O	O
metoprolol	metoprolol	NN	B-NP	O
75	75	CD	I-NP	O
mg	mg	NN	I-NP	O
po	po	NN	I-NP	O
q6	q6	NN	I-NP	O
hour	hour	NN	I-NP	O
Lisinopril	Lisinopril	NNP	B-NP	O
20mg	20mg	CD	I-NP	O
qd	qd	NN	I-NP	O
--	--	:	O	O
>	>	SYM	O	O
Captopril	Captopril	NNP	B-NP	O
25mg	25mg	NN	I-NP	O
Q8hr	Q8hr	NN	I-NP	O
cont	cont	NN	I-NP	O
.	.	.	O	O

Novasc	Novasc	NNP	B-NP	O
10mg	10mg	CD	I-NP	O
QD	QD	NNP	I-NP	O
,	,	,	O	O
Hold	Hold	NNP	B-NP	O
Imdur	Imdur	NNP	I-NP	O
and	and	CC	O	O
hydralazine	hydralazine	NN	B-NP	O
Would	Would	MD	B-VP	O
d/c	d/c	VB	I-VP	O
amlodipine	amlodipine	NN	B-NP	O
,	,	,	O	O
nitrates	nitrate	NNS	B-NP	O
and	and	CC	O	O
hydralazine	hydralazine	NN	B-NP	O
for	for	IN	B-PP	O
n	n	NN	B-NP	O
now	now	RB	B-ADVP	O
.	.	.	O	O

Pt	Pt	NN	B-NP	O
would	would	MD	B-VP	O
also	also	RB	I-VP	O
have	have	VB	I-VP	O
only	only	RB	B-NP	O
Lisinipril	Lisinipril	NNP	I-NP	O
upon	upon	IN	B-PP	O
discharge	discharge	NN	B-NP	O
.	.	.	O	O

4	4	LS	B-LST	O
.	.	.	O	O

Fluid	Fluid	NNP	B-NP	O
Level	Level	NNP	I-NP	O
-	-	HYPH	B-NP	O
Weight	Weight	NNP	I-NP	O
pat	pat	NN	I-NP	O
.	.	.	O	O

5	5	LS	B-LST	O
.	.	.	O	O

HEME	HEME	NN	B-NP	B-protein
:	:	:	O	O
D/C	D/C	NN	B-NP	O
lovenox	lovenox	NN	I-NP	O
.	.	.	O	O

Start	Start	NN	B-NP	O
IV	IV	CD	I-NP	O
Hepariin	Hepariin	NN	I-NP	O
and	and	CC	O	O
increase	increase	VB	B-VP	O
coumadin	coumadin	NN	B-NP	O
to	to	TO	B-PP	O
10mg	10mg	CD	B-NP	O
.	.	.	O	O

6	6	CD	B-NP	O
.	.	.	O	O

FEN	FEN	NN	B-NP	O
:	:	:	O	O
D/C	D/C	NN	B-NP	O
calcitrol	calcitrol	NN	I-NP	O
per	per	IN	B-PP	O
renal	renal	JJ	B-NP	O
team	team	NN	I-NP	O
7	7	CD	I-NP	O
.	.	.	O	O

PPx	PPx	NN	B-NP	O
cont	cont	NN	I-NP	O
.	.	.	O	O

on	on	IN	B-PP	O
coumadin	coumadin	NN	B-NP	O
.	.	.	O	O

Full	Full	NNP	B-NP	O
Code	Code	NNP	I-NP	O
***	***	NNP	I-NP	O
Of	Of	NNP	I-NP	O
Note	Note	NNP	I-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
following	follow	VBG	I-NP	O
medication	medication	NN	I-NP	O
changes	change	NNS	I-NP	O
were	be	VBD	B-VP	O
made	make	VBN	I-VP	O
:	:	:	O	O
1	1	LS	B-LST	O
.	.	.	O	O

Lisinopril	Lisinopril	NNP	B-NP	O
20	20	CD	I-NP	O
is	be	VBZ	B-VP	O
now	now	RB	B-ADVP	O
Lisinopril	Lisinopril	NNP	B-NP	O
2.5	2.5	CD	B-NP	O
2	2	CD	I-NP	O
.	.	.	O	O

Hydralazine	Hydralazine	NN	B-NP	O
and	and	CC	I-NP	O
Imdur	Imdur	NN	I-NP	O
are	be	VBP	B-VP	O
d/c	d/c	NN	B-NP	O
2/2	2/2	CD	I-NP	O
hypotension	hypotension	NN	I-NP	O
3	3	CD	I-NP	O
.	.	.	O	O

Coumadin	Coumadin	NN	B-NP	O
has	have	VBZ	B-VP	O
been	be	VBN	I-VP	O
increased	increase	VBN	I-VP	O
to	to	TO	B-PP	O
10mg	10mg	CD	B-NP	O
qd	qd	NN	I-NP	O
4	4	CD	I-NP	O
.	.	.	O	O

Toprol	Toprol	NN	B-NP	O
decreased	decrease	VBD	B-VP	O
from	from	IN	B-PP	O
300	300	CD	B-NP	O
to	to	TO	I-NP	O
150	150	CD	I-NP	O
mg	mg	NN	I-NP	O
qd	qd	NN	I-NP	O
ADDITIONAL	ADDITIONAL	NN	I-NP	O
COMMENTS	COMMENTS	NNS	I-NP	O
:	:	:	O	O
Please	Please	NN	B-NP	B-protein
let	let	VB	B-VP	O
Dr.	Dr.	NNP	B-NP	O
Brainard	Brainard	NNP	I-NP	O
know	know	VBP	B-VP	O
that	that	IN	B-SBAR	O
we	we	PRP	B-NP	O
reccomend	reccomend	VBP	B-VP	O
an	an	DT	B-NP	O
excersize	excersize	JJ	I-NP	O
stress	stress	NN	I-NP	O
test	test	NN	I-NP	O
as	as	IN	B-PP	O
an	an	DT	B-NP	O
out	out	JJ	I-NP	O
patient	patient	NN	I-NP	O
.	.	.	O	O

Plan	Plan	NN	B-NP	O
on	on	IN	B-PP	O
having	have	VBG	B-VP	O
your	your	PRP$	B-NP	O
INR	INR	NN	I-NP	B-protein
checked	check	VBD	B-VP	O
on	on	IN	B-PP	O
Monday	Monday	NNP	B-NP	O
-	-	HYPH	O	O
we	we	PRP	B-NP	O
have	have	VBP	B-VP	O
increased	increase	VBN	I-VP	O
your	your	PRP$	B-NP	O
coumadin	coumadin	NN	I-NP	O
to	to	TO	B-VP	O
10mg	10mg	VB	I-VP	O
a	a	DT	B-NP	O
day	day	NN	I-NP	O
.	.	.	O	O

DISCHARGE	DISCHARGE	NN	B-NP	O
CONDITION	CONDITION	NN	I-NP	O
:	:	:	O	O
Stable	Stable	JJ	B-NP	O
TO	TO	NN	I-NP	O
DO/PLAN	DO/PLAN	NN	I-NP	O
:	:	:	O	O
1	1	LS	B-LST	O
.	.	.	O	O

Please	Please	VB	B-VP	O
call	call	VB	I-VP	O
-LRB-	-LRB-	RP	B-PRT	O
248	248	CD	B-NP	O
-RRB-	-RRB-	SYM	I-NP	O
427-8413	427-8413	CD	I-NP	O
to	to	TO	B-VP	O
schedule	schedule	VB	I-VP	O
an	an	DT	B-NP	O
outpatient	outpatient	NN	I-NP	O
cardiac	cardiac	JJ	I-NP	O
stress	stress	NN	I-NP	O
test	test	NN	I-NP	O
.	.	.	O	O

2	2	LS	B-LST	O
.	.	.	O	O

Please	Please	VB	B-VP	O
follow	follow	VB	I-VP	O
up	up	RP	B-PRT	O
the	the	DT	B-NP	O
results	result	NNS	I-NP	O
of	of	IN	B-PP	O
your	your	PRP$	B-NP	O
outpatient	outpatient	NN	I-NP	O
labs	lab	NNS	I-NP	O
such	such	JJ	B-PP	O
as	as	IN	I-PP	O
SLE	SLE	NN	B-NP	O
work	work	NN	I-NP	O
up	up	RB	B-ADVP	O
and	and	CC	I-ADVP	O
also	also	RB	I-ADVP	O
HIV	HIV	NN	B-NP	O
test	test	NN	I-NP	O
with	with	IN	B-PP	O
your	your	PRP$	B-NP	O
primary	primary	JJ	I-NP	O
care	care	NN	I-NP	O
doctor	doctor	NN	I-NP	O
.	.	.	O	O

3	3	LS	B-LST	O
.	.	.	O	O

Follow	Follow	VB	B-VP	O
up	up	RP	B-PRT	O
your	your	PRP$	B-NP	O
INR	INR	NN	I-NP	O
tomorrow	tomorrow	NN	B-NP	O
with	with	IN	B-PP	O
the	the	DT	B-NP	O
coumadin	coumadin	NN	I-NP	O
clinic	clinic	NN	I-NP	O
.	.	.	O	O

4	4	LS	B-LST	O
.	.	.	O	O

Would	Would	MD	B-VP	O
Recommend	Recommend	VB	I-VP	O
the	the	DT	B-NP	O
outpatient	outpatient	NN	I-NP	O
MD	MD	NN	I-NP	O
to	to	TO	B-VP	O
stop	stop	VB	I-VP	O
the	the	DT	B-NP	O
Calcium	Calcium	NNP	I-NP	O
Blocker	Blocker	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
Norvasc	Norvasc	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
and	and	CC	O	O
give	give	VB	B-VP	O
beta	beta	SYM	B-NP	O
blocker	blocker	NN	B-NP	O
instead	instead	RB	B-ADVP	O
for	for	IN	B-PP	O
BP	BP	NN	B-NP	O
control	control	NN	I-NP	O
management	management	NN	I-NP	O
.	.	.	O	O

At	At	IN	B-PP	O
the	the	DT	B-NP	O
same	same	JJ	I-NP	O
time	time	NN	I-NP	O
,	,	,	O	O
pt	pt	NN	B-NP	O
would	would	MD	B-VP	O
need	need	VB	I-VP	O
to	to	TO	I-VP	O
put	put	VB	I-VP	O
back	back	RB	B-ADVP	O
on	on	IN	B-PP	O
his	his	PRP$	B-NP	O
BP	BP	NN	I-NP	O
as	as	IN	B-SBAR	O
needed	need	VBN	B-VP	O
.	.	.	O	O

No	No	DT	B-NP	O
dictated	dictated	JJ	I-NP	O
summary	summary	NN	I-NP	O
ENTERED	ENTERED	NNP	I-NP	O
BY	BY	NNP	I-NP	O
:	:	:	O	O
ACAL	ACAL	NNP	B-NP	O
,	,	,	O	O
MOSE	MOSE	NNP	B-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
-LRB-	-LRB-	NNP	I-NP	O
QU295	QU295	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
9/4/06	9/4/06	CD	I-NP	O
@	@	NN	I-NP	O
12	12	CD	I-NP	O
:	:	:	O	O
58	58	CD	B-NP	O
PM	PM	NN	I-NP	O
******	******	SYM	B-NP	O
END	END	NN	I-NP	O
OF	OF	IN	B-PP	O
DISCHARGE	DISCHARGE	NN	B-NP	O
ORDERS	ORDERS	NNS	I-NP	O
******	******	SYM	B-NP	O

